Li-ping H. Su
Taiyuan, 030013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Clinical Value of Detecting MYD88 L265P Mutation in the Plasma of Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma via Droplet Digital PCR
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
The Epigenetic Regulation of Decitabine Resistance in TP53 -Mutated Myelodysplastic Syndromes: Integrated Analysis Based on RNA-seq and Methylomics
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.
Journal: Cancer medicine
Published: February 01, 2025
Clinical Features and Prognosis of Patients with Diffuse Large B-Cell Lymphoma of the Breast
Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 31, 2024
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD.
Journal: Blood advances
Published: May 20, 2024
Clinical Characteristics and Correlation with Prognosis of DLBCL with Bone Marrow Involvement and Chromosomal Abnormalities
Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 17, 2023
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.
Journal: Science bulletin
Published: November 30, 2022
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Journal: The Lancet regional health. Western Pacific
Published: November 04, 2022
Evaluation of GELTAMO-IPI for Patients with Diffuse Large B-cell Lymphoma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: February 08, 2021
Last Updated: 09/26/2026